Atlas company financials

AMGEN INC

Standardized 19-year financial series for AMGEN INC, built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0000318154FY2007 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$36.8B

Adjusted EBITDA

—

Net result

$7.7B

Net financial debt

$45.5B

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$9.6B

TTM revenue

$35.4B

TTM free cash flow

—

Latest quarter net result

$3.2B

Quarterly coverage: 53 periods · latest quarter FY2025-Q3 · TTM revenue growth 19.1%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · amgen-inc-fy2007 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2010-03-01 · Retrieved: 2026-04-26T11:38:35.346133+00:00
SEC EDGAR companyfacts
primary · amgen-inc-fy2010 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-25 · Retrieved: 2026-04-26T11:38:35.346133+00:00
SEC EDGAR companyfacts
primary · amgen-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-29 · Retrieved: 2026-04-26T11:38:35.346133+00:00
SEC EDGAR companyfacts
us-gaap:CostOfGoodsSold · us gaap companyfacts · comparative · amgen-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-24 · Retrieved: 2026-04-26T11:38:35.346133+00:00
SEC EDGAR companyfacts
primary · amgen-inc-fy2012 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-27 · Retrieved: 2026-04-26T11:38:35.346133+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2007	15B	—	4B	3B	5B	-1B	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing cost of revenue · missing current assets · missing current liabilities · missing gross profit · missing interest expense · missing inventory · missing net financial debt · missing research and development · missing total assets
FY2008	15B	—	5B	4B	6B	-672M	-774M	comparative annual fact carried from later 10k · missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing research and development
FY2009	15B	—	6B	5B	6B	-530M	8B	missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing research and development
FY2010	15B	—	6B	5B	6B	-580M	10B	missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing research and development
FY2011	16B	—	4B	4B	5B	-567M	15B	missing adjusted ebitda · missing gross profit · missing interest expense · missing research and development
FY2012	17B	—	6B	4B	6B	-689M	26B	missing adjusted ebitda · missing gross profit · missing interest expense · missing research and development
FY2013	19B	—	6B	5B	6B	-693M	33B	missing adjusted ebitda · missing gross profit · missing interest expense · missing research and development
FY2014	20B	—	6B	5B	9B	-718M	27B

Filing provenance